Zurich Cantonal Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $959K | Buy |
|
|||||
|
2025
Q1 | $809K | Sell |
|
|||||
|
2024
Q4 | $962K | Buy |
|
|||||
|
2024
Q3 | $987K | Sell |
|
|||||
|
2024
Q2 | $731K | Buy |
|
|||||
|
2024
Q1 | $826K | Buy |
|
|||||
|
2023
Q4 | $772K | Buy |
|
|||||
|
2023
Q3 | $504K | Buy |
|
|||||
|
2023
Q2 | $546K | Buy |
|
|||||
|
2023
Q1 | $437K | Buy |
|
|||||
|
2022
Q4 | $462K | Buy |
|
|||||
|
2022
Q3 | $396K | Buy |
|
|||||
|
2022
Q2 | $505K | Sell |
|
|||||
|
2022
Q1 | $672K | Sell |
|
|||||
|
2021
Q4 | $860K | Buy |
|
|||||
|
2021
Q3 | $636K | Buy |
|
|||||
|
2021
Q2 | $671K | Sell |
|
|||||
|
2021
Q1 | $842K | Buy |
|
|||||
|
2020
Q4 | $963K | Buy |
|
|||||
|
2020
Q3 | $503K | Hold |
|
|||||
|
2020
Q2 | $479K | Buy |
|
|||||
|
2020
Q1 | $214K | Buy |
|
|||||
|
2019
Q4 | $142K | Hold |
|
|||||
|
2019
Q3 | $142K | Hold |
|
|||||
|
2019
Q2 | $211K | Buy |
|
|||||
|
2019
Q1 | $216K | Buy |
|
|||||
|
2018
Q4 | $125K | Hold |
|
|||||
|
2018
Q3 | $219K | Buy |
|
|||||
|
2018
Q2 | $184K | Hold |
|
|||||
|
2018
Q1 | $122K | Hold |
|
|||||
|
2017
Q4 | $111K | Buy |
|
|||||
|
2017
Q3 | $80K | Hold |
|
|||||
|
2017
Q2 | $94K | Sell |
|
|||||
|
2017
Q1 | $159K | Hold |
|
|||||
|
2016
Q4 | $165K | Buy |
|
|||||
|
2016
Q3 | $101K | Buy |
|
|||||
|
2016
Q2 | $40K | Hold |
|
|||||
|
2016
Q1 | $52K | Hold |
|
|||||
|
2015
Q4 | $93K | Buy |
|
|||||
|
2015
Q3 | $22K | Buy |
|
|||||
|
2015
Q2 | $10K | Hold |
|
|||||
|
2015
Q1 | $6K | Buy |
|